COMMUNIQUÉS West-GlobeNewswire

Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019
29/08/2019
August 29, 2019 European debut of latest release of Philips EPIQ CVx cardiology ultrasound platform extends advanced automation capabilities to make exams faster and easier to conduct Philips IntelliSpace Cardiovascular [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
29/08/2019
COPENHAGEN, Denmark, August 29, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 685,000 as a consequence of employees’ exercise of [...]
Correction: RAMSAY GENERALE DE SANTE : provisional annual results at the end of June 2019
29/08/2019
PRESS RELEASE Paris, 28 August 2019 Provisional annual results at the end of June 2019 Good results and solid perspectives Annual reported turnover up 51.7% to EUR 3,401.1 million. On a like-for-like basis, good growth [...]
LIDDS Delårsrapport april - juni 2019
29/08/2019
APRIL – JUNI 2019 Nettoomsättningen uppgick till 0,0 (0,0) MSEK Kostnaderna uppgick till 3,4 (2,2) MSEK Resultatet före och efter skatt uppgick till -3,4 (-2,2) MSEK Resultat per aktie uppgick till -0,15 (-0,11) SEK [...]
On “Grindeks” results in the first six months of 2019
29/08/2019
“Grindeks” profit in the first six months of 2019 increases by 14% and reaches 7.65 million euro Today, on August 29, JSC “Grindeks” submitted the non-audited consolidated financial statements of the first six months of [...]
Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients
29/08/2019
Press Release 29 August 2019 Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients --Ilixadencel in combination with Sutent [...]
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
29/08/2019
This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine Each year 300,000 patients around the world are diagnosed [...]
MDxHealth Reports Half Year 2019 Financial Results and Strategic Update
29/08/2019
Conference call with Q&A today at 11:00 CEST / 10:00 BST, details provided below IRVINE, CA, and HERSTAL, BELGIUM – August 29, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular [...]
MDxHealth dévoile ses résultats financiers pour le premier semestre de l’année 2019 et ses perspectives stratégiques
29/08/2019
Conférence téléphonique avec séance de questions-réponses aujourd’hui à 11 :00 CEST / 10:00 BST, voir détails ci-dessous IRVINE, CA, et HERSTAL, BELGIQUE – 29 août 2019 – MDxHealth SA (Euronext : MDXH.BR), une [...]
European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer
29/08/2019
The Tecentriq combination marks the first cancer immunotherapy regimen to be available in Europe for triple-negative breast cancer – an aggressive and difficult-to-treat disease Approval based on the Phase III [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES 2019 HALF-YEAR RESULTS ON 5 SEPTEMBER 2019
29/08/2019
PRESS RELEASE: REGULATED INFORMATION Thursday 29 August 2019, 07:00 CEST BIOCARTIS ANNOUNCES 2019 HALF-YEAR RESULTS ON 5 SEPTEMBER 2019 Mechelen, Belgium , 29 August 20 19 – Biocartis Group NV (the ‘Company’ or ‘ [...]
Vistin Pharma ASA: Second quarter 2019 financial results
29/08/2019
Oslo, Norway, 29 August 2019 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter of 2019, with an increase in revenue of 11%. The revenues for the second quarter [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28/08/2019
CRESTWOOD, Ky., and WALTHAM Mass, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
EDAP Reports 2019 Second Quarter Results
28/08/2019
Third consecutive profitable quarter Positive reimbursement decision by the American Medical Association announced in June Significant improvement in gross profit margin from 41.3% in Q2 2018 to 50.7% in Q2 2019 Q2 HIFU [...]
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9
28/08/2019
U.S. District Court invalidates Amgen patent claims targeting PCSK9 Court rules in favor of Sanofi and Regeneron in ongoing Praluent ® (alirocumab) patent litigation PARIS and TARRYTOWN, NY – August 28, 2019 – Sanofi [...]
Sanofi : Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9
28/08/2019
Le tribunal de district des États-Unis déclare invalides les revendications d’Amgen relatives aux brevets des anticorps ciblant PCSK9 Le tribunal statue en faveur de Sanofi et de Regeneron dans le cadre du litige en [...]
Osmotica Pharmaceuticals plc to Present at 2019 Wells Fargo Healthcare Conference
28/08/2019
BRIDGEWATER, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Andrew Einhorn, Chief [...]
PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10
28/08/2019
SPARTA, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]
Rockwell Medical, Inc. to Present at Upcoming September Conferences
28/08/2019
WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at two [...]

Pages